The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary FibrosisStefano Kette, Barbara Ruaro, Anna De Nes et al.|Pharmaceuticals|2025Cited by 6
Comorbidities’ Effect on IPF: Pathogenesis and ManagementAndrea Salotti, Barbara Ruaro, Micol Pividori et al.|Biomedicines|2025Cited by 3
First experience of a European reference network lung centre of sarcoidosis microangiopathyLucrezia Mondini, Barbara Ruaro, Maria Chianese et al.|Unknown|2025Cited by 0